Danaher Co. (NYSE:DHR) Shares Bought by Mirador Capital Partners LP

Mirador Capital Partners LP increased its stake in Danaher Co. (NYSE:DHR) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,505 shares of the conglomerate’s stock after acquiring an additional 904 shares during the period. Danaher makes up about 1.0% of Mirador Capital Partners LP’s holdings, making the stock its 26th largest holding. Mirador Capital Partners LP’s holdings in Danaher were worth $5,396,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of DHR. Coronation Fund Managers Ltd. increased its holdings in Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after buying an additional 1,470 shares during the last quarter. Moors & Cabot Inc. grew its holdings in shares of Danaher by 14.0% during the second quarter. Moors & Cabot Inc. now owns 2,540 shares of the conglomerate’s stock worth $635,000 after purchasing an additional 311 shares during the last quarter. Primecap Management Co. CA grew its holdings in shares of Danaher by 3.4% during the second quarter. Primecap Management Co. CA now owns 66,937 shares of the conglomerate’s stock worth $16,724,000 after purchasing an additional 2,200 shares during the last quarter. Bradley Foster & Sargent Inc. CT grew its holdings in shares of Danaher by 0.7% during the second quarter. Bradley Foster & Sargent Inc. CT now owns 553,940 shares of the conglomerate’s stock worth $138,402,000 after purchasing an additional 3,916 shares during the last quarter. Finally, E Fund Management Co. Ltd. grew its holdings in shares of Danaher by 12.2% during the second quarter. E Fund Management Co. Ltd. now owns 10,464 shares of the conglomerate’s stock worth $2,614,000 after purchasing an additional 1,136 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.3 %

Shares of DHR opened at $237.18 on Thursday. The firm has a market cap of $171.31 billion, a PE ratio of 45.26, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. The company’s fifty day moving average is $235.27 and its two-hundred day moving average is $253.56. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.02 EPS. Analysts forecast that Danaher Co. will post 7.49 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is 20.61%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on DHR. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Robert W. Baird dropped their price objective on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. KeyCorp raised their price objective on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Scotiabank initiated coverage on Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Finally, Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.